Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 18.35
(-2.18%)
CNY 18.35
(-2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 785.49 Million | -121.16 Million | 515.23 Million | 697.66 Million | 324.93 Million | 192.7 Million |
| Net Income | 187.49 Million | 338.73 Million | 543.72 Million | 443.62 Million | 287.79 Million | 268.89 Million |
| Depreciation & Amortization | 178.45 Million | 164.46 Million | 138.56 Million | 131.63 Million | 11.51 Million | 12.31 Million |
| Deferred income taxes | -2.57 Million | -5.19 Million | -3.39 Million | 589.65 Thousand | -2.43 Million | -940.3 Thousand |
| Stock-based compensation | -37.21 Million | 30.42 Million | - | - | - | - |
| Change in working capital | 394.08 Million | -741.59 Million | -235.93 Million | 70.66 Million | -155.27 Million | -264.81 Million |
| Other non-cash items | 11.45 Million | 91.99 Million | 68.88 Million | 51.73 Million | 180.89 Million | 176.3 Million |
| Investing Cash Flow | -502.04 Million | -556.54 Million | -200.83 Million | -190.72 Million | -179.57 Million | -24.49 Million |
| Investments in PPE | -497.47 Million | -547.96 Million | -200.48 Million | -126.72 Million | -148 Million | -173.82 Million |
| Acquisitions | 8.45 Million | -10 Million | -4.08 Million | -64 Million | -31.7 Million | -102.59 Million |
| Investment purchases | -15.5 Million | -100 Million | -380 Million | - | 148 Million | - |
| Sales/Maturities of investments | - | 101.36 Million | 383.66 Million | - | 139.67 Thousand | 1.98 Million |
| Other Investing Activities | -4.56 Million | 57.3 Thousand | 71.01 Thousand | -126.72 Million | -148 Million | 249.93 Million |
| Financing Cash Flow | -432.19 Million | -101.6 Million | -408.27 Million | 1.63 Billion | -7.73 Million | -420.58 Million |
| Debt repayment | -139.69 Million | -9 Million | -160.03 Million | -437.37 Million | -420.35 Million | -636.43 Million |
| Dividends payments | -495 Million | -306 Million | -202.5 Million | -22.17 Million | -25.76 Million | -31.08 Million |
| Common Stock Repurchased | -54.98 Million | - | 21.1 Million | 5.69 Million | - | - |
| Common Stock Issuance | - | - | -21.1 Million | -5.69 Million | - | - |
| Other Financing Activities | -66.76 Million | 215.37 Million | -43.3 Million | 2.09 Billion | 438.38 Million | 246.93 Million |
| Accounts receivables | 278.3 Million | -531.26 Million | -305.23 Million | 184.23 Million | -53.97 Million | -242.6 Million |
| Accounts payables | - | 531.26 Million | 305.23 Million | -184.23 Million | 53.97 Million | - |
| Inventory | -30.6 Million | -158.22 Million | -26.07 Million | -91.04 Million | 121.43 Million | -220.15 Million |
| Other working capital | 148.97 Million | -583.37 Million | -209.85 Million | 161.71 Million | -276.71 Million | -44.65 Million |
| Cash at beginning of period | 1.51 Billion | 2.29 Billion | 2.38 Billion | 244.65 Million | 107.01 Million | 359.31 Million |
| Cash at end of period | 1.37 Billion | 1.51 Billion | 2.29 Billion | 2.38 Billion | 244.65 Million | 107.01 Million |
| Capital Expenditure | -497.47 Million | -547.96 Million | -200.48 Million | -126.72 Million | -148 Million | -173.82 Million |
| Effect of forex changes on cash | 3.93 Million | 6.2 Million | -913.35 Thousand | -1.36 Million | 16.76 Thousand | 83.92 Thousand |
| Net cash flow / Change in cash | -144.81 Million | -773.11 Million | -94.78 Million | 2.14 Billion | 137.63 Million | -252.29 Million |
| Free Cash Flow | 288.01 Million | -669.13 Million | 314.75 Million | 570.94 Million | 176.92 Million | 18.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 91.17 Million | 49.24 Million | 69.3 Million | 35.98 Million | 187.49 Million | -54.8 Million |
| Depreciation & Amortization | - | 52.54 Million | 52.54 Million | 48.48 Million | 178.45 Million | -81.72 Million |
| Deferred income taxes | - | - | - | - | -2.57 Million | 209.73 Million |
| Stock-based compensation | - | - | - | -37.21 Million | -37.21 Million | 37.21 Million |
| Change in working capital | - | 159.59 Million | - | 210.48 Million | 394.08 Million | -165.22 Million |
| Other non-cash items | 97.8 Million | 98.67 Million | 76.82 Million | -35.98 Million | 11.45 Million | 63.46 Million |
| Investing Cash Flow | -127.9 Million | -101.37 Million | -90.83 Million | -84.51 Million | -502.04 Million | -152.14 Million |
| Investments in PPE | -75.74 Million | -91.71 Million | -90.96 Million | -85.09 Million | -497.47 Million | -155.77 Million |
| Acquisitions | 847.54 Thousand | 342.95 Thousand | 124.8 Thousand | 578.94 Thousand | 8.45 Million | 3.38 Million |
| Investment purchases | -53 Million | -10 Million | - | - | -15.5 Million | 5.06 Million |
| Sales/Maturities of investments | - | - | - | - | - | -5.06 Million |
| Other Investing Activities | - | -9.65 Million | 124.8 Thousand | 578.94 Thousand | -4.56 Million | 239.81 Thousand |
| Financing Cash Flow | 8.81 Million | -201.33 Million | 189.26 Million | -90.92 Million | -432.19 Million | 15.73 Million |
| Debt repayment | -16.68 Million | -3.64 Million | -218.73 Million | -103.13 Million | -139.69 Million | -109.2 Million |
| Dividends payments | - | -94.61 Million | -4.43 Million | -495 Million | -495 Million | -495 Million |
| Common Stock Repurchased | - | - | - | -54.98 Million | -54.98 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.86 Million | -198.61 Million | -25.02 Million | -192.72 Million | -66.76 Million | 127.59 Million |
| Accounts receivables | - | 195.23 Million | - | 278.3 Million | 278.3 Million | -209.57 Million |
| Accounts payables | - | - | - | - | - | -37.21 Million |
| Inventory | - | -35.63 Million | - | -30.6 Million | -30.6 Million | 44.34 Million |
| Other working capital | - | - | - | -37.21 Million | 148.97 Million | 37.21 Million |
| Cash at beginning of period | 1.5 Billion | 1.73 Billion | 1.37 Billion | 1.25 Billion | 1.51 Billion | 1.38 Billion |
| Cash at end of period | 1.55 Billion | 1.5 Billion | 1.61 Billion | 1.37 Billion | 1.37 Billion | 1.25 Billion |
| Capital Expenditure | -75.74 Million | -91.71 Million | -90.96 Million | -85.09 Million | -497.47 Million | -155.77 Million |
| Effect of forex changes on cash | - | 452.16 Thousand | 120.75 Thousand | 63.84 Thousand | 3.93 Million | 312.01 Thousand |
| Net cash flow / Change in cash | 44.92 Million | -226.49 Million | 244.68 Million | 114.21 Million | -144.81 Million | -127.43 Million |
| Free Cash Flow | 113.22 Million | 3.66 Million | 55.16 Million | 204.5 Million | 288.01 Million | -147.1 Million |
TGHLF
BANCOINDIA
2469
DEEPAKCHEM
AKRIT
POPULARES